Taken together, inclusion of VSV‐GP into the treatment regimen led to an increase in the number of activated CD8 T cells in the tumor relative to the PBS and DCVacc groups, whereby the number of OVA‐specific cells was not higher in the DCVacc/VSV‐GP than in the DCVacc group. Here, CD8A is linked to neoplasm.